Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.
Antegenes has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in August 2022.
Antegenes's investors include Enterprise Estonia, EIT - European Institute of Innovation and Technology, Timo Rein, Peep Vain, Aare Kurist.
Antegenes is headquartered in Tartu, Estonia.
Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.
Antegenes is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Antegenes — Funding & Investors." VCBacked, August 2, 2022, https://www.vcbacked.co/company/antegenes. Accessed September 30, 2026.
VCBacked. (2022). Antegenes — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/antegenes
{{cite web |title=Antegenes — Funding & Investors |url=https://www.vcbacked.co/company/antegenes |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated